We are live on !
Find out more
ST
SAL Trading Portfolio holdings
AUM
$57M
Turnover
76.47%
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+33.89%
3 Year Est. Return
+18.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57M
AUM Growth
-$1.19M
(-2%)
Cap. Flow
-$6.98M
Cap. Flow % of AUM
Cap. Flow %
-12.25%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
17
New
5
Increased
1
Reduced
1
Closed
8
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rio Tinto
RIO
|
+$718K |
| 2 |
Frontline
FRO
|
+$558K |
| 3 |
ArcelorMittal
MT
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.14M |
| 2 |
British American Tobacco
BTI
|
+$924K |
| 3 |
BP
BP
|
+$848K |
| 4 |
Ferrari
RACE
|
+$613K |
| 5 |
CMB.TECH NV
CMBT
|
+$187K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.89% |
| 2 | Materials | 2.3% |
| 3 | Healthcare | 1.85% |
| 4 | Energy | 0.95% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$795B
| $47M | 82.43% |
81,899
| – | – |
2024 Q1
2 quarters
|
|
2
CALL
GSK
GSK
$98.4B
| $4.06M | 7.12% |
+99,300
| New | +$4.06M |
2024 Q3
0 quarters
|
|
|
3
PUT
GSK
GSK
$98.4B
| $2.07M | 3.63% |
+50,600
| New | +$2.07M |
2024 Q3
0 quarters
|
|
4
argenx
ARGX
$55B
| $1.06M | 1.85% |
1,949
| – | – |
2023 Q3
4 quarters
|
|
|
5
Rio Tinto
RIO
$135B
| $796K | 1.4% |
+11,185
| New | +$718K |
2024 Q3
0 quarters
|
|
|
6
CALL
argenx
ARGX
$55B
| $705K | 1.24% |
1,300
+800
| +160% | +$404K |
2023 Q2
5 quarters
|
|
|
7
Frontline
FRO
$11.6B
| $542K | 0.95% |
+23,700
| New | +$558K |
2024 Q3
0 quarters
|
|
|
8
ArcelorMittal
MT
$46B
| $517K | 0.91% |
+19,700
| New | +$451K |
2024 Q3
0 quarters
|
|
|
9
PUT
argenx
ARGX
$55B
| $271K | 0.48% |
500
-1,600
| -76% | -$809K |
2023 Q3
4 quarters
|
|
|
10
AstraZeneca
AZN
$289B
| – | – |
-39,351
| Closed | -$6.14M | – |
|
11
CALL
BHP
BHP
$203B
| – | – |
-15,100
| Closed | -$862K | – |
|
|
12
PUT
BHP
BHP
$203B
| – | – |
-22,200
| Closed | -$1.27M | – |
|
|
13
BP
BP
$123B
| – | – |
-23,500
| Closed | -$848K | – |
|
|
14
British American Tobacco
BTI
$133B
| – | – |
-29,869
| Closed | -$924K | – |
|
|
15
Ferrari
RACE
$70.6B
| – | – |
-1,500
| Closed | -$613K | – |
|
|
16
CALL
Rio Tinto
RIO
$135B
| – | – |
-12,500
| Closed | -$824K | – |
|
|
17
CMB.TECH NV
CMBT
$5.34B
| – | – |
-11,300
| Closed | -$187K | – |
|
Similar funds
SVG
TM
BCM
MAM
SAL Trading's Q3 2024 Portfolio in Review
As of Q3 2024, SAL Trading held 17 positions worth $57M, down 2% from $58.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SAL Trading withdrew a net $6.98M in Q3 2024, closing 8 positions and reducing 1 holding. Its most notable exit was AstraZeneca, an estimated $6.14M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 84% a quarter earlier, followed by Materials and Healthcare.
Against the trend, SAL Trading opened a new position in Rio Tinto worth $796K.
- SAL Trading's largest Q3 2024 buy was Rio Tinto: 11,185 shares worth $796K.
- SAL Trading fully exited AstraZeneca in Q3 2024, selling an estimated $6.14M.
- SAL Trading's ten largest holdings make up 100% of its $57M portfolio in Q3 2024.
- SAL Trading opened 5 new positions and closed 8 in Q3 2024.
- SAL Trading's portfolio value fell 2% quarter-over-quarter to $57M.
Based on SAL Trading's 13F filing for Q3 2024, filed 14 Nov 2024.